B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy Report from the 2021 SH/EAHP Workshop

Online journal article in Hematopathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

list the types of histiocytic/dendritic cell neoplasms (HCDN) that may be detected as transdifferentiated neoplasms in patients originally diagnosed with...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

list the types of histiocytic/dendritic cell neoplasms (HCDN) that may be detected as transdifferentiated neoplasms in patients originally diagnosed with malignant B-cell neoplasms.
apply mutational analysis to HCDN for more precise cell-lineage identification.
discuss possible therapeutic targets for transdifferentiated HDCNs.

View More View Less